Haselmeier™ A medmix Brand

Your Partner from technology to therapy – As expert in subcutaneous drug delivery systems for self-administration, Haselmeier provides innovative and award-winning individual system solutions to support patients for a successful therapy. Haselmeier primarily works with pharmaceutical and biotechnology companies to improve the lives of patients by manufacturing pens and auto-injectors that are convenient, reliable and that can be dosed with precision. The family business covers all steps – from design to planning to industrialization – in the creation of high-quality self-injection systems. In 2020, this well-established company will be able to look back on a 100-year-old success story. Spread across seven global locations on three different continents, the Haselmeier Group employs a workforce of more than 240 people. www.haselmeier.com

We are part of medmix.

The products shown are under development and some of them may not yet have been approved for sale under applicable medical devices regulation. The content provides general information about these products, their field of application and intended use, and their function, performance and specification are subject to customer specific development and may deviate from those shown herein. All information contained herein is directed at medical devices manufacturer and pharmaceutical companies. This information shall not constitute a promotion for use in a way which conflicts with any applicable medical devices regulation nor is it directed at patients or intended to replace professional medical advice.

Company’s Keywords:

medical devices, injection devices, drug delivery, connected solutions, subcutaneous selfinjection, connected devices, fertility, osteoporoses, diabetes, glp1, oncology, clinical trials, product development, drug manufacturing, pharmaceutical manufacturing, manufacturing, growth hormones